Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.56 |
| ▸ | LCK | P06239 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | GRB2 | P62993 | 1/20 | 0.56 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.55 |
| ▸ | MIF | P14174 | 8/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | GLA | P06280 | 3/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2274941 | 1.00 | POLB (0.57) | POLBAKR1B1LCKFYNGRB2 | |
| SCHEMBL9436016 | 0.85 | KDM4E (0.54) | POLBAKR1B1HSD17B3MIFKDM4E | |
| SCHEMBL11128154 | 0.83 | NPC1 (0.55) | HSD17B3MIFMEN1KMT2AMAPT | |
| SCHEMBL29066603 | 0.82 | ESR2 (0.61) | POLBAKR1B1HSD17B3MIFKDM4E | |
| SCHEMBL220708 | 0.82 | HSD17B3 (0.65) | POLBAKR1B1HSD17B3MIFKDM4E | |
| SCHEMBL30405545 | 0.82 | HSD17B3 (0.65) | POLBAKR1B1HSD17B3MIFKDM4E | |
| SCHEMBL10845026 | 0.82 | CA12 (0.50) | POLBAKR1B1MIFKDM4EMEN1 | |
| SCHEMBL6037595 | 0.81 | POLB (0.59) | POLBAKR1B1HSD17B3MIFKDM4E | |
| SCHEMBL2403666 | 0.81 | RAB9A (0.59) | POLBAKR1B1KDM4EMEN1KMT2A | |
| SCHEMBL28164061 | 0.81 | POLB (0.59) | POLBAKR1B1HSD17B3MIFKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719450-A2 | MODIFIED CAVEOLIN-1 PEPTIDE FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF | Rein Therapeutics, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024249565-A2 | MODIFIED CAVEOLIN-1 PEPTIDE FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF | LUNG THERAPEUTICS, LLC (US) | 2024-12-05 | — | — | WO | disclosed |
| WO-2023154916-A2 | COMPOSITIONS AND METHODS FOR TREATING INFECTIOUS DISEASES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20230212223-A1 | MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS | LUNG THERAPEUTICS, INC. (US) | 2023-07-06 | — | — | US | disclosed |
| EP-4168031-A2 | MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF PATHOGEN-INDUCED LUNG INJURY | Lung Therapeutics, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| WO-2022217037-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC LUNG DISEASES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-10-13 | — | — | WO | disclosed |